DocSym
β
Searchsearch
Search
(G11.0) Congenital nonprogressive ataxia
More details coming soon
149 554 in individuals diagnosis congenital nonprogressive ataxia confirmed
16 151 deaths with diagnosis congenital nonprogressive ataxia
11% mortality rate associated with the disease congenital nonprogressive ataxia
Diagnosis congenital nonprogressive ataxia is diagnosed Men are 20.27% more likely than Women
89 937
Men receive the diagnosis congenital nonprogressive ataxia
8 312 (9.2 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
59 617
Women receive the diagnosis congenital nonprogressive ataxia
7 839 (13.1 %)Died from this diagnosis.
Risk Group for the Disease congenital nonprogressive ataxia - Men aged 45-49 and Women aged 55-59
In Men diagnosis is most often set at age 0-94
Less common in men the disease occurs at Age 0-1, 95+Less common in women the disease occurs at Age 0-1, 90-95+
In Women diagnosis is most often set at age 0-89
Disease Features congenital nonprogressive ataxia
Absence or low individual and public risk
Congenital nonprogressive ataxia - what does this mean
Congenital nonprogressive ataxia is a neurological disorder which is present from birth and does not worsen over time. it is caused by a genetic mutation which affects the development of the cerebellum, the part of the brain responsible for controlling balance and coordination. this results in a lack of coordination, unsteady gait, and difficulty with fine motor skills.
What happens during the disease - congenital nonprogressive ataxia
Congenital nonprogressive ataxia is a rare neurological disorder caused by a genetic mutation that affects the development of the cerebellum. this mutation results in poor coordination and balance, as well as difficulty with speech and movement. the exact cause of the mutation is unknown, but it is believed to be related to structural and functional abnormalities in the cerebellum. these abnormalities can lead to a wide range of motor and cognitive deficits, including difficulty walking, speaking, and maintaining balance.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Complete medical history and physical examination
- Neurological examination
- Genetic testing
- CT scan or MRI of the brain
- Electroencephalogram (EEG)
- Blood tests to check for metabolic disorders
- Urine tests to check for metabolic disorders
- Lumbar puncture (spinal tap) to check for infection or inflammation
- Muscle biopsy to check for muscle damage
Treatment and Medical Assistance
Main goal: To improve the patient's quality of life and reduce the symptoms of the disease.
- Physical therapy to improve coordination, balance, and muscle strength
- Occupational therapy to help the patient learn how to perform daily activities
- Speech therapy to help improve communication
- Cognitive therapy to help the patient compensate for any cognitive difficulties
- Counseling to provide emotional support
- Medications to help reduce symptoms such as tremors
- Assistive devices to help the patient with mobility
24 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Congenital nonprogressive ataxia - Prevention
The best way to prevent congenital nonprogressive ataxia is to ensure that pregnant women receive adequate nutrition, avoid exposure to toxins, and receive regular prenatal care. in addition, genetic counseling may be beneficial for families with a history of ataxia.